CD274 and non-small cell lung carcinoma: In conclusion, we assessed the expression heterogeneity of PD-L1 in a large cohort of patients with NSCLC using tissue cores as surrogates of biopsies using two cutoffs (≥ 1% and ≥ 50% of cells) and found discordant results in a significant number of cases.